NPPA Cuts MRP of 1,364 Anti-Cancer Formulations from 9 November
Lower retail prices of 1,364 anti-cancer formulations took effect on 9 November 2026 after NPPA capped trade margins on 137 cancer drugs, saving Rs 3,540.38 crore.

Why in News
On 9 November 2026 the revised maximum retail prices of 1,364 anti-cancer formulations came into effect, after the National Pharmaceutical Pricing Authority capped the trade margin on 137 anti-cancer drugs on the advice of a DGHS expert committee.
Cancer medicines became cheaper across the country on 9 November 2026. The National Pharmaceutical Pricing Authority (NPPA) has placed a ceiling on the trade margin that may be built into the maximum retail price of cancer drugs, and the reworked rates apply from that day. No chemist and no hospital pharmacy may now charge more than the new printed price.
Who took the decision
The authority functions under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers. Its order covers 137 anti-cancer drugs. It rests on the advice of an expert committee set up by the Directorate General of Health Services (DGHS) in the Ministry of Health and Family Welfare, whose recommendations are dated 17 October 2026.
How far the prices fell
Drug makers had to work out the new ceilings and report them to the regulator. By 8 November 2026, 85 pharmaceutical companies had filed revised retail prices for 1,364 anti-cancer formulations, which together cover 121 drugs. The cut crossed half the old price in 679 brands, and the steepest single reduction reported to the authority was 96.45 per cent. Adding up every reported cut, the regulator expects buyers of these medicines to be spared roughly Rs 3,540.38 crore in a year.
| Drugs under the trade margin cap | 137 |
| Formulations with revised prices | 1,364 |
| Drugs these formulations cover | 121 |
| Companies that reported | 85 |
| Brands cheaper by over half | 679 |
| Largest reduction reported | 96.45 per cent |
| Expected yearly saving | Rs 3,540.38 crore |
What a patient should do
The revised rate is printed on the medicine pack, so the first check is the pack itself. The price can also be looked up on the Pharma Sahi Daam mobile app or on the NPPA website. If a shop or a hospital pharmacy bills more than the ceiling, the buyer can complain on the Pharma Jan Samadhan portal or ring the NPPA helpline on 1800-111-255.
Why the trade margin matters
A trade margin is the share of the retail price that is taken between the manufacturer and the counter. Capping it leaves the medicine itself unchanged but shrinks what is added on the way to the patient, which is why a single order was able to reduce prices in hundreds of brands at once. Cancer treatment usually runs over many months, so a lower ceiling on each pack keeps adding up for a family through the course of therapy.
Important Facts
| Regulator | National Pharmaceutical Pricing Authority (NPPA) |
|---|---|
| Comes under | Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers |
| Drugs under trade margin cap | 137 anti-cancer drugs |
| Formulations repriced | 1,364 formulations, covering 121 drugs |
| Companies reporting new prices | 85 pharmaceutical companies (as on 8 November 2026) |
| Brands cheaper by more than half | 679 brands |
| Steepest reduction reported | 96.45 per cent |
| Expected annual saving | Rs 3,540.38 crore |
| Revised prices effective from | 9 November 2026 |
| Expert committee | Set up by the Directorate General of Health Services, Ministry of Health and Family Welfare; recommendations of 17 October 2026 |
| Where to check the price | Medicine pack, Pharma Sahi Daam mobile app, NPPA website |
| Where to complain | Pharma Jan Samadhan portal or NPPA helpline 1800-111-255 |
Exam Point of View
Note the regulator (NPPA) and where it sits (Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers); the counts of 137 drugs capped, 1,364 formulations repriced, 121 drugs covered, 85 companies reporting and 679 brands cheaper by over half; the largest cut of 96.45 per cent; the yearly saving of Rs 3,540.38 crore; the effective date of 9 November 2026; the DGHS expert committee behind it; and the two consumer tools, the Pharma Sahi Daam app and the Pharma Jan Samadhan portal.
Practice Questions
Revised maximum retail prices have been reported for how many anti-cancer formulations, which came into effect on 9 November 2026?
- A.137
- B.1,364
- C.121
- D.679
Show answer
As on 8 November 2026, eighty-five pharmaceutical companies had reported revised maximum retail prices for 1,364 anti-cancer formulations, and those prices came into force on 9 November 2026.
Read the full explanation →Which authority capped the trade margins on the maximum retail price of 137 anti-cancer drugs?
- A.Central Drugs Standard Control Organisation
- B.Food Safety and Standards Authority of India
- C.National Pharmaceutical Pricing Authority
- D.Directorate General of Health Services
Show answer
The NPPA works under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers, and it is the body that capped trade margins on the retail prices of 137 anti-cancer drugs, with the revised rates applying from 9 November 2026.
Read the full explanation →What is the estimated annual saving to consumers from the revised prices of anti-cancer medicines?
- A.Rs 1,364 crore
- B.Rs 2,540.38 crore
- C.Rs 3,540.38 crore
- D.Rs 679 crore
Show answer
That is the yearly saving the National Pharmaceutical Pricing Authority expects consumers to make once the reduced maximum retail prices of the anti-cancer formulations are in force from 9 November 2026.
Read the full explanation →What was the highest reduction in the maximum retail price reported for an anti-cancer medicine?
- A.50 per cent
- B.67.45 per cent
- C.85 per cent
- D.96.45 per cent
Show answer
The correct answer is 96.45 per cent, the steepest cut in a maximum retail price reported to the National Pharmaceutical Pricing Authority after it capped trade margins on anti-cancer drugs.
Read the full explanation →Frequently Asked Questions
How many anti-cancer formulations have become cheaper from 9 November 2026?
Revised maximum retail prices have been reported for 1,364 anti-cancer formulations, covering 121 drugs, by 85 pharmaceutical companies. The prices took effect on 9 November 2026 after NPPA capped the trade margin on 137 anti-cancer drugs.
How much will patients save because of the lower cancer drug prices?
The National Pharmaceutical Pricing Authority estimates the annual saving to consumers at about Rs 3,540.38 crore. In 679 brands the price fell by more than half, and the steepest reduction reported was 96.45 per cent.
Where can a patient verify the new price of a cancer medicine?
The revised maximum retail price is printed on the pack. It can also be checked on the Pharma Sahi Daam mobile app or the NPPA website. Overcharging by a chemist or a hospital pharmacy can be reported on the Pharma Jan Samadhan portal or on the NPPA helpline 1800-111-255.
Sources
- https://www.pib.gov.in/PressReleasePage.aspx?PRID=2334268 (opens in a new tab) — Press Information Bureau
Current Affairs 9 November 2026
- Buddha Relics Enshrined at Bomdila Monastery in ArunachalNational
- Uttarakhand Statehood Day: PM Greets Devbhoomi on 9 NovemberImportant Days
- Exercise Rahat Mitra: India-Myanmar HADR Drill Ends in ChennaiDefence
- Swachh Survekshan 2025-26 Awards: President to Honour Cleanest CitiesAwards & Honours
Related Current Affairs
- Economy
NFDB 13th Governing Body Meet in Hyderabad Chaired by Lalan Singh
6 November 2026 · 2 min read
Related GK
- Famous Personalities of Rajasthan: Exam Notes
28 October 2026 · Rajasthan
- Districts and Divisions of Rajasthan: Exam Notes
28 October 2026 · Rajasthan
- Tourism and World Heritage Sites of Rajasthan Notes
27 October 2026 · Rajasthan
Take the Quiz
- Current Affairs Quiz
State Exams Current Affairs Quiz: 9 November 2026
18 questions18 minutesStart Quiz





